Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …

Vaccination updates and special considerations for systemic... : Current Opinion in
Rheumatology Vaccination updates and special considerations for systemic lupus erythematosus …

Background This study aimed to compare the occurrence of adverse events (AEs) and
disease flares after vaccination against coronavirus disease 2019 (COVID-19) and influenza …

COVID-19 vaccination has been shown to be safe in patients with systemic lupus
erythematosus (SLE), but data on vaccine-associated adverse events (AEs) during the …

Patients with autoimmune inflammatory rheumatic diseases (AIIRD) are potentially at a
higher risk of contracting the SARS-CoV-2 virus and have poorer outcomes of the infection …

Objective To determine the occurrence of breakthrough COVID-19 infections (BIs) in patients
with systemic lupus erythematosus (SLE) compared with patients with other rheumatic …

Background: The safety profile of COVID-19 vaccination is well documented, but hesitancy
among people with immune-mediated inflammatory diseases, often immunocompromised …

This study aimed to assess the incidence, predictors, and outcomes of breakthrough
infection (BI) following coronavirus disease (COVID-19) vaccination in patients with systemic …

Objectives To identify the effectiveness and safety of inactivated SARS‐CoV‐2 vaccines in
rheumatic and musculoskeletal diseases (RMDs) patients. Methods RMD patients with …

Objectives To compare adverse events and flares among different doses and types of
COVID‐19 vaccines in patients with systemic lupus erythematosus (SLE). Methods All …